Jacobs Levy Equity Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $210K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $2.29M | Sell |
|
|||||
|
2022
Q3 | $24.8M | Buy |
|
|||||
|
2022
Q2 | $878K | Sell |
|
|||||
|
2022
Q1 | $1.3M | Sell |
|
|||||
|
2021
Q4 | $3.84M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $1.06M | Sell |
|
|||||
|
2019
Q3 | $3.21M | Buy |
|
|||||
|
2019
Q2 | $3.1M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $699K | Sell |
|
|||||
|
2016
Q1 | $1.45M | Buy |
|